Takehara K, Moroi Y, Ishibashi Y
Br J Dermatol. 1985 Jan;112(1):23-33. doi: 10.1111/j.1365-2133.1985.tb02287.x.
Antinuclear antibodies were studied by indirect immunofluorescence and double immunodiffusion in 21 patients with systemic sclerosis and 35 of their relatives. When HEp-2 cells were used as the substrate, the frequency of antinuclear antibodies in the patients' sera was 100% and that in the relatives was 26%. When rat liver sections were used, the values were 86% and 17%, respectively. Anticentromere antibody was detected in the serum from the mother of one patient whose serum had anti-Scl-70 antibody. Antibody to n-RNP was positive in the sera from the brother and daughter of another patient whose serum was positive for anti-n-RNP and anti-Scl-70 antibodies. The high frequency of antinuclear antibodies in the sera from the relatives of systemic sclerosis patients suggests that immunological abnormalities play a part in the pathogenesis of this condition.
采用间接免疫荧光法和双向免疫扩散法,对21例系统性硬化症患者及其35名亲属的抗核抗体进行了研究。以人喉癌上皮细胞(HEp-2细胞)为底物时,患者血清中抗核抗体的检出率为100%,亲属血清中抗核抗体的检出率为26%。以大鼠肝切片为底物时,相应的值分别为86%和17%。在一名血清中有抗Scl-70抗体的患者的母亲血清中检测到了抗着丝点抗体。在另一名血清中抗核核糖核蛋白(n-RNP)和抗Scl-70抗体均呈阳性的患者的兄弟及女儿的血清中,n-RNP抗体呈阳性。系统性硬化症患者亲属血清中抗核抗体的高检出率表明,免疫异常在该病的发病机制中起作用。